文献速递乳房整形与再造创面修复

SERI™手术支架在保留皮肤乳房切除术后直接植入重建中的应用:手术结局的回顾性研究及当前文献的系统综述

The use of SERI™ Surgical Scaffolds in direct-to-implant reconstruction after skin-sparing mastectomy: A retrospective study on surgical outcomes and a systematic review of current literature.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2018-02-15

回顾性分析16例(22侧)保留皮肤乳房切除术后使用SERI手术支架行直接植入重建的患者,中位随访27个月,术后血清肿10侧(45%)、支架相关并发症3侧(14%),均表现为支架未整合。同时系统检索170篇文献纳入9篇综述,作者认为支架相关并发症可能比既往报道更常见,需进一步研究。

要点

  • 16例(22侧)直接植入重建中,术后血清肿10侧(45%)、手术部位感染2侧(9%)。
  • 支架相关并发症3侧(14%),均为支架未整合,其中2侧皮肤溃疡、1侧支架游离于乳房腔并被血清肿包围。
  • 作者认为支架未整合等支架相关并发症可能比既往描述更常见。

核心结论

  • 丝源性支架在乳房重建中的作用尚未确定;作者认为支架相关并发症如支架未整合可能比既往描述更常见,需进一步研究以确定其在特定患者群体中的可能优劣。

研究设计与样本

  • 回顾性 chart 研究纳入所有保留皮肤乳房切除术后使用SERI手术支架行直接植入重建的患者,记录手术特征、围手术期并发症和再手术。
  • 系统文献综述聚焦报告SERI在乳房手术中应用的临床前和临床研究,从170篇文献中纳入9篇进行综述。
  • 共识别16例患者(22侧乳房),手术时平均年龄47±6.8岁,平均BMI 23.1±3.1 kg/m2,平均切除重量530±221 g,中位临床随访27个月(范围25-37)。

主要发现

  • 无术中并发症;术后需再手术的出血发生于1侧(5%)乳房,术后血清肿10侧(45%),手术部位感染2侧(9%)。
  • 支架相关并发症发生于3侧(14%)乳房,均包括支架未整合,其中2侧导致皮肤溃疡,1侧支架游离于乳房腔并被血清肿包围。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Little is reported on surgical outcomes of SERI Surgical Scaffold, a bioresorbable silk-derived surgical scaffold, developed to provide soft-tissue support and repair, in implant/expander breast reconstruction. METHODS: A retrospective chart study was conducted of all patients who underwent direct-to-implant reconstruction with a SERI surgical scaffold after skin-sparing mastectomy, recording surgical characteristics, perioperative complications and reoperations. A systematic literature review was conducted focusing on preclinical and clinical studies reporting on use of SERI in breast surgery. RESULTS: A total of 16 patients (22 breasts) were identified (mean age at surgery was 47 ± 6.8 years, mean BMI 23.1 ± 3.1 kg/m2, mean ablation weight 530 ± 221 g, median clinical follow-up time 27 months (range 25-37)). There were no intraoperative complications. Postoperative bleeding, that required reoperation occurred in one (5%) breast, postoperative seroma in 10 (45%) and surgical site infection in 2 (9%). Scaffold-related complications occurred in 3 (14%) breasts, comprising lack of scaffold integration in all, resulting in skin ulceration in 2 and the scaffold lying free in the breast pocket surrounded with seroma in one. Nine articles were selected and reviewed from the 170 identified. DISCUSSION: The role of silk-derived scaffolds in breast reconstruction is yet to be determined. Though first reports have shown promising results, our and others results suggest that scaffold-related complications, such as lack of scaffold integration, may occur more frequently than previously described. Further research is necessary to determine possible (dis)advantages of the scaffold in specific patient groups.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. van Turnhout AAWM, Franke CJJ, Vriens-Nieuwenhuis EJC, et al. The use of SERI™ Surgical Scaffolds in direct-to-implant reconstruction after skin-sparing mastectomy: A retrospective study on surgical outcomes and a systematic review of current literature. J Plast Reconstr Aesthet Surg. 2018. PMID: 29398609. doi:10.1016/j.bjps.2018.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。